sotorasib
Brand: LUMAKRAS
approved
Quick answer
sotorasib (LUMAKRAS), is a pharmaceutical active ingredient, with approved status in the US.
Key facts
- INN
- sotorasib
- Brand
- LUMAKRAS
- Route
- ORAL
- Formulation
- TABLET
Related news
FDA Grants Priority Review to Sotorasib for KRAS G12C NSCLC
Sotorasib receives FDA priority review for KRAS G12C non-small cell lung cancer (NSCLC), marking a pivotal step in targeted cancer treatment.
FDA Approves Breakthrough KRAS Inhibitor Lumakras for Lung Cancer
The FDA has approved Lumakras, a groundbreaking KRAS inhibitor, providing a new targeted therapy option for patients battling lung cancer.
Frequently asked questions
What is sotorasib?
sotorasib (LUMAKRAS), is a pharmaceutical active ingredient, with approved status in the US.
What is the brand name for sotorasib?
LUMAKRAS is a marketed brand name for sotorasib. Check FDA Drugs@FDA for the current US label holder.